C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21–22 October 2001 - Palmer, JP; Fleming, GA; Greenbaum, CJ (Diabetes, 2004)